December 10, 2018
With 2018 coming to a close, here's a look at the biggest genetics trends of the year and what's in...
December 3, 2018
What gene therapy companies should be on investors' radar? Here are four promising companies to consider looking at in 2018.
November 25, 2018
In-licensing may be pharma’s preferred mode of business development these days. Should that impact your investment strategy?
November 13, 2018
CRISPR Cas-9 gene editing is finally in clinical studies. Here's an overview of CRISPR genetics testing trials currently in progress.
October 14, 2018
A look at 10 drugs going off patent in 2018, plus an overview of what loss of exclusivity means for...
April 29, 2018
Eleven Biotherapeutics, EyePoint Pharmaceuticals, Avid Bioservices, Cerecor and Celldex were last week's top gainers on the NASDAQ.
April 4, 2018
These companies are engaged in a wide range of compelling research around everything from respiratory devices and inflatable tissue to...